ECLAXIR:Search for an Association Between CX3CR1 V249I Polymorphism, Preeclampsia and Endothelial Injury
|Study Design:||Time Perspective: Retrospective|
|Study Start Date:||March 2003|
|Study Completion Date:||October 2007|
|Primary Completion Date:||October 2007 (Final data collection date for primary outcome measure)|
It is a case-control multicenter study 185 caucasian pregnant women with preeclampsia and 185 paired controls without preeclampsia will be included.
The frequency of the V249I polymorphism in african black population will be determined by studying 200 subjects (100 cases and 100 controls).
The V249I polymorphism will be identified by PCR followed by enzyme digestion. Endothelial injury will be identified using three assays : von Willebrand factor, soluble VCAM-1 and thrombomodulin plasma levels.
CX3CR1 involvement in preeclampsia would have potential diagnostic and therapeutic consequences.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00190177
|Hôpital Louis Mourier AP-HP|
|Colombes, France, 92701|
|Principal Investigator:||Laurent Mandelbrot, MD-PhD||Assistance Publique - Hôpitaux de Paris|